Fir Tree Capital Management’s Orion Biotech Opportunities Corp. Warrant ORIAW Stock Holding History

Fir Tree Capital Management’s Portfolio ORIAW Stock Details ORIAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-200,000	Closed	-$36K	–	445
2022 Q3	$36K	Hold	200,000	–	–	﹤0.01%	447
2022 Q2	$31K	Hold	200,000	–	–	﹤0.01%	558
2022 Q1	$74K	Hold	200,000	–	–	﹤0.01%	554
2021 Q4	$192K	Hold	200,000	–	–	0.01%	518
2021 Q3	$175K	Buy	+200,000	New	+$260K	0.01%	424

Other funds holding ORIAW

RCM

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.32B AUM 1.82% 1-Year Est. Return

AGC

Angelo Gordon & Co New York $1.06B AUM 47.95% 1-Year Est. Return

SCM

Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return

AFM

Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return

GAM

Gritstone Asset Management Bethesda, Maryland $104M AUM 6.03% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

KIM LLC Wichita, Kansas $1B AUM 29.68% 1-Year Est. Return

Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return

Fir Tree Capital Management's ORIAW Position: Q4 2022 in Review

Fir Tree Capital Management sold out of Orion Biotech Opportunities Corp. Warrant (ORIAW) in Q4 2022, closing a stake of 200,000 shares — an estimated $36K sold.

Fir Tree Capital Management first reported a position in ORIAW in Q3 2021 and held it in 5 quarters. The position peaked at $192K in Q4 2021. 29 funds tracked by Wall St. Rank hold ORIAW as of Q4 2022.

Fir Tree Capital Management reported no remaining Orion Biotech Opportunities Corp. Warrant position as of Q4 2022 after selling out during the quarter.
Fir Tree Capital Management sold 200,000 Orion Biotech Opportunities Corp. Warrant shares in Q4 2022, an estimated $36K.
Fir Tree Capital Management first reported a position in Orion Biotech Opportunities Corp. Warrant in Q3 2021 and held it in 5 quarters.
Fir Tree Capital Management's Orion Biotech Opportunities Corp. Warrant position peaked at $192K in Q4 2021.
29 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Warrant as of Q4 2022.

Based on Fir Tree Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.